TABLE 2:

Clinical features of 11 patients with ICA occlusion

Patient/Age(y)/Sex	Initial Occlusion Site^*	Urokinase Dose (U)	Time from Onset (min)			Occlusion Site after Procedure	NIHSS Score			mRS Score at 3 mo
Patient/Age(y)/Sex	Initial Occlusion Site^*	Urokinase Dose (U)	Admission	Start of Angiography	End of Procedure	Occlusion Site after Procedure	Initial	24 h	3 mo	mRS Score at 3 mo
13/69/M	R C3/prox M1	600,000	60	120	240	C M3	20	13	7	3
14/73/F	R C1/prox M1	420,000	180	210	270	P M3	16	2	0	0
15/76/M	L C2/prox M1	420,000	40	70	150	Angular M4	25	21	11	2
16/69/F	R C4/prox M1	600,000	120	150	240	C4	19	11	7	3
17/82/F	L C3/mid M1	600,000	60	110	210	Angular M4	28	25	24	5
18/66/M	R C1/mid M1	480,000	60	100	170	No	21	8	0	0
19/58/M	L C1/mid M1	420,000	50	80	150	No	26	13	5	2
20/78/F^†	L C4/prox M1	480,000	190	240	300	M2	26	18	14	3
21/83/M	L C3/distal M1	420,000	40	100	180	Angular M4 A4	28	23	23	5
22/69/M^‡	R C2/mid M1	480,000	70	120	220	C M4	17	13	11	4
23/61/M^§	L C2/distal M1	600,000	50	110	300	FCM2 A4	29	28	Dead	Dead

Note.—A4 indicates the supracallosal segment of the anterior cerebral artery; C1, knee portion of the ICA; C2, cisternal portion of the ICA; C3, anterior knee of the ICA; C4, cavernous portion of the ICA; dist M1, distal third of the M1; prox M1, proximal third of the M1; mid M1, middle third of the M1.
* Proximal end/distal end of clot.
† Perforation.
‡ L leg embolism.
§ Massive cerebral infarct.